Open Access

Polyhexamethylene biguanide functionalized cationic silver nanoparticles for enhanced antimicrobial activity

  • Sumaira Ashraf1, 3,
  • Nasrin Akhtar1,
  • Muhammad Afzal Ghauri1,
  • Muhammad Ibrahim Rajoka1, 2,
  • Zafar M Khalid1 and
  • Irshad Hussain3Email author
Nanoscale Research Letters20127:267

DOI: 10.1186/1556-276X-7-267

Received: 21 March 2012

Accepted: 23 April 2012

Published: 24 May 2012

Abstract

Polyhexamethylene biguanide (PHMB), a broad spectrum disinfectant against many pathogens, was used as a stabilizing ligand for the synthesis of fairly uniform silver nanoparticles. The particles formed were characterized using UV-visible spectroscopy, FTIR, dynamic light scattering, electrophoretic mobility, and TEM to measure their morphology and surface chemistry. PHMB-functionalized silver nanoparticles were then evaluated for their antimicrobial activity against a gram-negative bacterial strain, Escherichia coli. These silver nanoparticles were found to have about 100 times higher bacteriostatic and bactericidal activities, compared to the previous reports, due to the combined antibacterial effect of silver nanoparticles and PHMB. In addition to other applications, PHMB-functionalized silver nanoparticles would be extremely useful in textile industry due to the strong interaction of PHMB with cellulose fabrics.

Keywords

Cationic silver nanoparticles Polyhexamethylene biguanide Antimicrobial activity

Background

Antimicrobial activity of silver nanoparticles (Ag NPs) is well documented, and they are currently being used in a variety of commercial antimicrobial products including textile products and paints etc. [16]. Although the mechanism of their antimicrobial activity is not completely understood yet, silver, whether in the form of ionic or metallic state, is known to destabilize and increase the permeability of bacterial membranes [7]. It results in the collapse of the plasma membrane potential, disruption of ion transport processes, and the depletion of the levels of intracellular ATP [810]. Silver also inactivates essential respiratory enzymes and proteins responsible for RNA and DNA replication in bacteria [7, 11, 12]. Ag NPs can penetrate inside the microbial cells, damaging sulfur and phosphorus containing compounds such as DNA and proteins [9, 1315]. Although Ag NPs form complexes with various amino acids to inhibit protein's function, their toxicity to the mammalian cells is very limited, thus, warranting their antimicrobial applications in medical and healthcare products [1620].

Due to the growing interest in the use of Ag NPs to develop antimicrobial products, various methods are being developed for their preparation with a fair control over their size, shape, and the surface chemistry [5, 2126]. Recent studies have shown that antimicrobial properties of Ag NPs are significantly affected by their nanoscale dimensions (size and shape) and the surface ligands/charge, and thus, the efforts are being made to produce Ag NPs with the highest possible antimicrobial properties to minimize the load of nanoparticles in any commercial products without compromising their antimicrobial activity [5, 2126]. One such elegant approach has recently been reported to integrate the antimicrobial properties of an enzyme, lysozyme, with those of silver nanoparticles, and the resulting hybrid nanoparticles showed improved microbial toxicity over other preparations [27]. In order to increase the repertoire of effective antimicrobial products, we have now integrated the antimicrobial property of polyhexamethylene biguanide (PHMB) with that of silver nanoparticles, and to the best of our knowledge, the antimicrobial activity of these hybrid silver nanoparticles is much higher than the previous reports. PHMB is a positively charged polymer having polymeric biguanide units in the backbone of its structure [−(CH2)6.NH.C(=NH).NH.C(=NH).NH-] n , where n ranges from 2 to 40 having an average value of 11 [28]. It is being used in medicine [2935], textile, and food industry [36, 37] as an antiseptic agent since many years due to its broad spectrum antibacterial effect. PHMB acts as a bacteriostatic if administered at low concentrations, i.e., from 1 to 10 μg/mL and as bactericidal at high doses, i.e., ≥10 μg/mL [3840]. It damages the membrane integrity by nonspecifically interacting with acidic lipid residues of cytoplasmic membrane [41, 42]. PHMB also affects nucleic acids due to its strong interaction with them causing structural and functional changes in the microbial genome [43]. Keeping in view the widespread antimicrobial applications of PHMB, we set out to coat it on silver nanoparticles to develop a hybrid product with enhanced antimicrobial properties. Using Escherichia coli as a model microorganism, the bacteriostatic and bactericidal concentrations of these cationic hybrid silver nanoparticles were found to be 0.075 and 0.15 μg/mL, respectively, which are much higher than the previous reports on silver nanoparticles. Figure 1 shows a simple cartoon to demonstrate the antibacterial activity of PHMB-functionalized silver nanoparticles.
https://static-content.springer.com/image/art%3A10.1186%2F1556-276X-7-267/MediaObjects/11671_2012_Article_1009_Fig1_HTML.jpg
Figure 1

The interaction of PHMB-functionalized silver nanoparticles with the bacteria to demonstrate their antibacterial activity.

Methods

PHMB (20% w/v) was purchased from Arch Chemicals (Norwalk, CT, USA). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA), except tryptone, agar, and yeast extract which were purchased from MP Biomedicals (Santa Ana, CA, USA), and were used as received without further purification. Pure strain of E. coli was provided by Invitrogen (Carlsbad, CA, USA). Luria Bertani (LB) medium, used for the growth study of E. coli, was prepared using 1% tryptone, 0.5% yeast extract, and 1% sodium chloride in water, and pH was adjusted to 7 using 0.5 M solution of sodium hydroxide and hydrochloric acid. Ultrapure water with a resistivity of 18.2 MΩ cm was used as the solvent in all preparations.

Synthesis of Ag NPs

In a typical experiment to prepare PHMB functionalized Ag NPs, a given volume of PHMB aqueous solution, starting from 0.5 to 200 μg/mL (ideally, 15 mL, 20 μg/mL), was added to an aqueous solution of AgNO3 (25 mL, 1 mM) under vigorous stirring. The reaction mixture was stirred vigorously for 2 h to let PHMB form a complex with silver. Freshly prepared aqueous solution of sodium borohydride (5 mL, 0.8 mg/mL) was then added quickly to PHMB-Ag solution, and the reaction was allowed to complete for 5 h. The yellow/brownish suspension of silver nanoparticles was then filter purified to remove excess PHMB and other impurities using centrifuge filters (Amicon® Ultra centrifugal filters by Millipore Corporation, Billerica, MA, USA ) having a molecular weight cutoff value of 30 KDa and then stored at room temperature for further analysis and use in subsequent experiments.

Antimicrobial activity of PHMB-functionalized Ag NPs

In order to study the effect of PHMB-stabilized Ag NPs on bacterial growth, E. coli strain was grown on an agar plate, and its fresh colony was transferred with the help of a sterilized loop into a shake flask which was then incubated in an incubator shaker for 12 h at 37°C at a shaking speed of 150 rpm under aerobic conditions. The growth of bacteria was measured by taking optical density (OD) of samples at 600 nm. When the OD of growth culture approached 1 at 600 nm, the bacterial culture was then transferred into new shake flasks at a density of 2.5% bacteria into each flask. Different concentrations of clean PHMB-coated Ag NPs were then added in triplicate starting from 0.075 to 0.15 μg/mL of Ag NPs (different tested concentrations of Ag NPs were 0.075, 0.09, 0.1, 0.12, 0.135, and 0.15 μg/mL) into shake flasks just before inoculating with E. coli. Same concentrations of Ag NPs were also added into the LB media for the purpose of control experiment to serve as a blank while measuring their OD at 600 nm. All these shake flasks containing E. coli strains and Ag NPs, along with controls, were placed in an incubator shaker for 24 h at 37°C at a shaking speed of 150 rpm. The growth of bacteria was monitored by measuring OD of samples at regular intervals at 600 nm. The bacterial growth curves were then plotted against time based on the data obtained by carefully monitoring the bacterial growth. Based on these growth curves, the effect of silver nanoparticles on specific growth rate and doubling time of E. coli was observed.

Characterization

Transmission electron microscopy of Ag NPs was carried out using a high-resolution transmission electron microscope (JEOL, JEM-3010, JEOL Ltd., Akishima, Tokyo, Japan) operating at 300 kV. Nanoparticle specimens, for inspection by transmission electron microscopy, were prepared by slow evaporation of one drop of a dilute aqueous solution of the particles on a carbon-coated copper mesh grid. ImageJ software was used to calculate the particle size distribution from transmission electron micrographs. The particle size distribution and surface potential of nanoparticles were determined using Zetasizer Nano ZS (Malvern Instruments, Westborough, MA, USA). The surface chemistry of Ag NPs was determined using Bruker Alpha-P FTIR (Bruker Optik Gmbh, Ettlingen, Germany) with a diamond ATR attachment. UV-visible spectrum of Ag NPs suspension was recorded using an Agilent 8453 UV-visible spectrophotometer (Agilent Technologies Inc., Santa Clara, CA, USA). The approximate concentration of Ag NPs was determined using fast sequential atomic absorption spectrometer (AA240FS) by Varian Inc., Palo Alto, CA, USA.

Results and discussion

Antimicrobial activity of Ag NPs is well known and is believed to be dependent on the size [21, 22], shape [5, 23, 24], surface bound ligands [25, 26], and their subsequent surface charge [44]. Recently, it was reported that the surface charge of Ag NPs is the most important factor in this regard while studying the effect of neutral, positively, and negatively charged Ag NPs on the growth of gram-positive bacteria belonging to bacillus species [44]. Negatively charged Ag NPs were found to be the most effective to retard the growth of these bacteria. In this study, we have prepared Ag NPs which are positively charged and, in addition, are functionalized with a known antimicrobial agent, PHMB, to enhance the antimicrobial properties of Ag NPs towards gram-negative bacteria.

Since smaller Ag NPs are considered to have higher antimicrobial activity [21, 22], we produced Ag NPs using borohydride-reduction method in the presence of PHMB. The so-formed particles were fairly uniform as indicated by their narrow surface plasmon resonance (SPR) bands shown in Figure 2. The size of Ag NPs, however, varied a bit by varying the concentration of PHMB, and the most uniform nanoparticles were obtained using 15 mL of 20 μg/mL PHMB, while keeping other reaction conditions constant, as indicated by their narrowest SPR band (Figure 2). Using lesser concentration of PHMB, the yield of nanoparticles decreased and their polydispersity increased as indicated by a decrease in the intensity and broadening of their SPR bands. By increasing the concentration of PHMB, the PHMB-Ag complex precipitated forming a milky suspension before the addition of reducing agent. Transmission electron micrographs of Ag NPs under optimum conditions, shown in Figure 3a, show that they are fairly round and uniform in size. In order to calculate the size and size dispersity of Ag NPs, we measured the size of at least 300 particles using an ImageJ program, and their histogram shows that about 75% of these particles are in the size range ca. 5 to 9 nm (Figure 3b). Dynamic light scattering (DLS) characterization showed that the majority of the particles were of ca. 60 to 140 nm in size (see in Additional file 1: Figure S1). The larger size is because DLS measures the hydrodynamic diameter of the particles which includes the size of the capping ligands and the solvent shell.
https://static-content.springer.com/image/art%3A10.1186%2F1556-276X-7-267/MediaObjects/11671_2012_Article_1009_Fig2_HTML.jpg
Figure 2

UV-visible absorption spectra of silver nanoparticles produced using different concentrations of PHMB. The inset shows the optical image of dispersed silver nanoparticles.

https://static-content.springer.com/image/art%3A10.1186%2F1556-276X-7-267/MediaObjects/11671_2012_Article_1009_Fig3_HTML.jpg
Figure 3

Transmission electron micrograph of PHMB-stabilized silver nanoparticles (a) and the histogram of their size distribution (b).

After the formation of Ag NPs, they were purified using ultracentrifugation filters to ensure the complete removal of excess PHMB. The complete removal of excess PHMB was confirmed by analyzing the filtrate using FTIR spectroscopy, and centrifuge filtration was repeated unless no characteristic IR transmission peaks of PHMB were observed. In order to confirm that PHMB remains bound to the clean nanoparticles' surface, we measured the surface potential of clean particles which was found to be +53 mV indicating the presence of positively charged PHMB on nanoparticles' surface (see in Additional file 1: Figure S2). In order to further confirm the functionalization of silver nanoparticles with PHMB, they were characterized using FTIR spectroscopy which is a valuable tool to characterize various functional groups in organic molecules. PHMB shows sharp spectral peaks between 1,200 and 1,700 cm−1 as shown in its FTIR spectrum (Figure 4). Its strong absorption peak centered at 1,536 cm−1 is disappeared in PHMB-modified Ag NPs indicating the interaction of imine groups of PHMB with the nanoparticles.
https://static-content.springer.com/image/art%3A10.1186%2F1556-276X-7-267/MediaObjects/11671_2012_Article_1009_Fig4_HTML.jpg
Figure 4

FTIR spectra of PHMB (a) and PHMB-stabilized silver nanoparticles (b).

After confirming the presence of PHMB on the surface of clean Ag NPs, we set out to determine their antimicrobial activity. Ag NPs are well known for their antimicrobial activity, and their bacteriostatic and bactericidal concentrations are usually found in the range of 5 and 50 μg/mL, respectively [5, 7, 25, 4550]. In order to improve the antimicrobial activity and broaden its spectrum, we conjugated Ag NPs with an antimicrobial agent, PHMB. PHMB, if used alone, shows bactericidal activity beyond 10 μg/mL [38]. The bacteriostatic and bactericidal activities of PHMB-functionalized Ag NPs were, however, improved to be 0.075 and 0.150 μg/mL, respectively.

Figure 5 shows the growth curves of E. coli in the absence and presence of varying concentrations (0.075 to 0.15 μg/mL) of PHMB-functionalized Ag NPs. It is evident from these growth curves that E. coli was unable to grow for about 10 h even in the presence of the lowest concentration (0.075 μg/mL) of PHMB-functionalized Ag NPs used. Even after 10 h, the growth rate was very slow, and the total bacterial biomass produced after 24 h was less than one third of that produced in control experiment containing no Ag NPs. The bacterial biomass was estimated by taking optical density of the samples withdrawn at regular intervals during bacterial growth. The growth curves also indicate that E. coli was unable to grow in the presence of 0.15 μg/mL or higher concentration of PHMB-functionalized Ag NPs even after 24 h. At this bactericidal concentration of Ag NPs, the black aggregates of E. coli were clearly visible floating in the growth media showing the aggregation of bacteria. The aggregation of bacteria at bactericidal concentration of many antimicrobial agents is already known and is usually attributed to the charge neutralization of bacterial cell's surface in case of PHMB [24]. These results thus show more than 100 times increase in the bacteriostatic and bactericidal activities of these cationic Ag NPs compared to the previous reports on Ag NPs. It is worth noticing that PHMB, when used alone (3 μg/mL) as a control, had no significant effect on the trend of bacterial growth which is in accordance with the previous finding [38].
https://static-content.springer.com/image/art%3A10.1186%2F1556-276X-7-267/MediaObjects/11671_2012_Article_1009_Fig5_HTML.jpg
Figure 5

Effect of the concentration of PHMB-stabilized silver nanoparticles on the growth of E. coli .

Based on the bacterial growth in the presence and absence of PHMB-functionalized Ag NPs, the specific growth rate (increase in cell mass per unit time, μ (per hour)) and doubling time td (hours) for E. coli were also calculated (Table 1). It is evident from the values of specific growth rate and doubling time for E. coli that maximum specific growth rate (0.92 ± 0.03 h−1) and minimum doubling time (0.75 ± 0.02 h) were observed in the absence of functionalized Ag NPs. However, the specific growth rate was decreased and doubling time increased by increasing the concentration of PHMB-functionalized Ag NPs. In the presence of PHMB alone (3 μg/mL), the effect on the specific growth rate and doubling time of E. coli was not much significant as shown in Table 1.
Table 1

Effect of concentrations of silver nanoparticles

Concentration of Ag NPs in E. coli culture (μg/mL)

Specific growth rateμ (h-1)

Doubling timetd(h)

0

0.92 ± 0.03

0.75 ± 0.02

0.075

0.25 ± 0.01

2.8 ± 0.01

0.090

0.20 ± 0.01

3.4 ± 0.01

0.100

0.197 ± 0.01

3.52 ± 0.01

0.120

0.18 ± 0.01

4.31 ± 0.01

0.135

0.15 ± 0.01

4.6 ± 0.01

0.150

0.11 ± 0.01

6.3 ± 0.02

PHMB alone (3 μg/mL)

0.788 ± 0.03

0.879 ± 0.02

Conclusions

To summarize, a cationic biocide (PHMB) was used for the synthesis of fairly uniform silver nanoparticles. The cationic silver particles thus formed showed much higher antibacterial activity against E. coli than the previous reports. PHMB is routinely used in textile industry due to its antimicrobial activity and affinity to the cellulose fabrics. Therefore, these PHMB-coated silver nanoparticles with enhanced antimicrobial activity may have very useful applications in textile industry.

Declarations

Acknowledgements

We gratefully acknowledge Higher Education Commission (HEC), Government of Pakistan, for the financial support to Sumaira Ashraf during her PhD studies. We are also thankful to ex-National Commission on Nanoscience and Technology (NCNST) and Ministry of Science and Technology (MoST), Government of Pakistan for the financial support to initiate nano-biotechnology research at NIBGE. IH thanks LUMS School of Science & Engineering (SSE), Lahore, Pakistan for start-up funds to initiate nanomaterial research at LUMS. We are also thankful to Professor Wolfgang Parak for his support to characterize nanoparticle samples.

Authors’ Affiliations

(1)
National Institute for Biotechnology and Genetic Engineering (NIBGE)
(2)
Department of Bioinformatics and Biotechnology, Government College University
(3)
Department of Chemistry, School of Science & Engineering (SSE), Lahore University of Management Sciences (LUMS), DHA

References

  1. Dubas ST, Wacharanad S, Potiyaraj P: Tunning of the antimicrobial activity of surgical sutures coated with silver nanoparticles. Colloids Surf A 2011, 380: 25–28. 10.1016/j.colsurfa.2011.01.037View ArticleGoogle Scholar
  2. Dubas ST, Pimpan V: Green synthesis of silver nanoparticles for ammonia sensing. Talanta 2008, 76: 29–33. 10.1016/j.talanta.2008.01.062View ArticleGoogle Scholar
  3. Chen J, Luo Y, Liang Y, Jiang J, Shen G, Yu R: Surface-enhanced Raman scattering for immunoassay based on the biocatalytic production of silver nanoparticles. Anal Sci 2009, 25: 347–352. 10.2116/analsci.25.347View ArticleGoogle Scholar
  4. Kim S, Kim HJ: Anti-bacterial performance of colloidal silver-treated laminate wood flooring. Int Biodeterior Biodegrad 2006, 57: 155–162. 10.1016/j.ibiod.2006.02.002View ArticleGoogle Scholar
  5. Morones J, Elechiguerra J, Camacho A, Holt K, Kouri J, Ram J, Yacaman M: The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16: 2346–2353. 10.1088/0957-4484/16/10/059View ArticleGoogle Scholar
  6. Kumar A, Vemula PK, Ajayan PM, John G: Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat Mater 2008, 7: 236–241. 10.1038/nmat2099View ArticleGoogle Scholar
  7. Sondi I, Salopek-Sondi B: Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 2004, 275: 177–182. 10.1016/j.jcis.2004.02.012View ArticleGoogle Scholar
  8. Dibrov P, Dzioba J, Gosink KK, Häse CC: Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae . Antimicrob Agents Chemother 2002, 46: 2668–2670. 10.1128/AAC.46.8.2668-2670.2002View ArticleGoogle Scholar
  9. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO: A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus . J Biomed Mater Res 2000, 52: 662–668. 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3View ArticleGoogle Scholar
  10. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PKH, Chiu JF, Che CM: Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007, 12: 527–534. 10.1007/s00775-007-0208-zView ArticleGoogle Scholar
  11. Lansdown ABG: Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2006, 33: 17–34.View ArticleGoogle Scholar
  12. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PKH, Chiu JF, Che CM: Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006, 5: 916–924. 10.1021/pr0504079View ArticleGoogle Scholar
  13. Yamanaka M, Hara K, Kudo J: Bactericidal actions of a silver ion solution on Escherichia coli , studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 2005, 71: 7589–7593. 10.1128/AEM.71.11.7589-7593.2005View ArticleGoogle Scholar
  14. Bragg P, Rainnie D: The effect of silver ions on the respiratory chain of Escherichia coli . Can J Microbiol 1974, 20: 883–889. 10.1139/m74-135View ArticleGoogle Scholar
  15. McDonnell G, Russell A: Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 1999, 12: 147.Google Scholar
  16. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ: Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 2004, 54: 1019–1024. 10.1093/jac/dkh478View ArticleGoogle Scholar
  17. Ohashi S, Saku S, Yamamoto K: Antibacterial activity of silver inorganic agent YDA filler. J Oral Rehabil 2004, 31: 364–367. 10.1111/j.1365-2842.2004.01200.xView ArticleGoogle Scholar
  18. Maneerung T, Tokura S, Rujiravanit R: Impregnation of silver nanoparticles into bacterial cellulose for antimicrobial wound dressing. Carbohydr Poly 2008, 72: 43–51. 10.1016/j.carbpol.2007.07.025View ArticleGoogle Scholar
  19. Durán N, Marcato PD, Alves OL, De Souza GIH, Esposito E: Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J Nanobiotechnology 2005, 3: 8–14. 10.1186/1477-3155-3-8View ArticleGoogle Scholar
  20. Son WK, Youk JH, Lee TS, Park WH: Preparation of antimicrobial ultrafine cellulose acetate fibers with silver nanoparticles. Macromol Rapid Commun 2004, 25: 1632–1637. 10.1002/marc.200400323View ArticleGoogle Scholar
  21. Wigginton NS, Titta A, Piccapietra F, Dobias J, Nesatyy VJ, Suter MJF, Bernier-Latmani R: Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity. Environ Sci Technol 2010, 44: 2163–2168. 10.1021/es903187sView ArticleGoogle Scholar
  22. Dal Lago V, de Oliveira LF, de Almeida Gonçalves K, Kobarg J, Cardoso MB: Size-selective silver nanoparticles: future of biomedical devices with enhanced bactericidal properties. J Mater Chem 2011, 21: 12267–12273. 10.1039/c1jm12297eView ArticleGoogle Scholar
  23. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ: Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology 2005, 3: 1–10. 10.1186/1477-3155-3-1View ArticleGoogle Scholar
  24. Pal S, Tak YK, Song JM: Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli . Appl Environ Microbiol 2007, 73: 1712–1720. 10.1128/AEM.02218-06View ArticleGoogle Scholar
  25. Zhang Y, Peng H, Huang W, Zhou Y, Yan D: Facile preparation and characterization of highly antimicrobial colloid Ag or Au nanoparticles. J Colloid Interface Sci 2008, 325: 371–376. 10.1016/j.jcis.2008.05.063View ArticleGoogle Scholar
  26. Schäfer B, Tentschert J, Luch A: Nanosilver in consumer products and human health: more information required! Environ Sci Technol 2011, 45: 7589–7590. 10.1021/es200804uView ArticleGoogle Scholar
  27. Eby DM, Schaeublin NM, Farrington KE, Hussain SM, Johnson GR: Lysozyme catalyzes the formation of antimicrobial silver nanoparticles. ACS Nano 2009, 3: 984–994. 10.1021/nn900079eView ArticleGoogle Scholar
  28. Rowhani T, Lagalante AF: A colorimetric assay for the determination of polyhexamethylene biguanide in pool and spa water using nickel-nioxime. Talanta 2007, 71: 964–970. 10.1016/j.talanta.2006.07.042View ArticleGoogle Scholar
  29. Hiti K, Walochnik J, Haller-Schober E, Faschinger C, Aspöck H: Viability of Acanthamoeba after exposure to a multipurpose disinfecting contact lens solution and two hydrogen peroxide systems. Brit J Ophthalmol 2002, 86: 144–146. 10.1136/bjo.86.2.144View ArticleGoogle Scholar
  30. Rosin M, Welk A, Bernhardt O, Ruhnau M, Pitten FA, Kocher T, Kramer A: Effect of a polyhexamethylene biguanide mouthrinse on bacterial counts and plaque. J Clin Periodontol 2001, 28: 1121–1126. 10.1034/j.1600-051X.2001.281206.xView ArticleGoogle Scholar
  31. Rosin M, Welk A, Kocher T, Majic-Todt A, Kramer A, Pitten F: The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque regrowth. J Clin Periodontol 2002, 29: 392. 10.1034/j.1600-051X.2002.290503.xView ArticleGoogle Scholar
  32. Messick CR, Pendland SL, Moshirfar M, Fiscella RG, Losnedahl KJ, Schriever CA, Schreckenberger PC: In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis. J Antimicrob Chemother 1999, 44: 297–298. 10.1093/jac/44.2.297View ArticleGoogle Scholar
  33. Donoso R, Mura J, Lopez M: Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB). Rev Méd Chile 2002, 130: 396–401.View ArticleGoogle Scholar
  34. Gray TB, Gross KA, Cursons R, Shewan JF: Acanthamoeba keratitis: a sobering case and a promising new treatment. Aust N Z J Ophthalmol 1994, 22: 73–76. 10.1111/j.1442-9071.1994.tb01700.xView ArticleGoogle Scholar
  35. Narasimhan S, Madhavan HN: Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea 2002, 21: 203–205. 10.1097/00003226-200203000-00016View ArticleGoogle Scholar
  36. Cazzaniga A, Serralta V, Davis S, Orr R, Eaglstein W, Mertz PM: The effect of an antimicrobial gauze dressing impregnated with 0.2-percent polyhexamethylene biguanide as a barrier to prevent Pseudomonas aeruginosa wound invasion. Wounds 2002, 14: 169–176.Google Scholar
  37. Payne J, Kudner D: A new durable antimicrobial finish for cotton textiles. Am Dyestuff Rep 1996, 85: 26–30.Google Scholar
  38. Allen MJ, White GF, Morby AP: The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 2006, 152: 989–1000. 10.1099/mic.0.28643-0View ArticleGoogle Scholar
  39. Broxton P, Woodcock P, Gilbert P: A study of the antibacterial activity of some polyhexamethylene biguanides towards Escherichia coli ATCC 8739. J Appl Microbiol 1983, 54: 345–353. 10.1111/j.1365-2672.1983.tb02627.xGoogle Scholar
  40. Gilbert P, Pemberton D, Wilkinson DE: Barrier properties of the gram negative cell envelope towards high molecular weight polyhexamethylene biguanides. J Appl Microbiol 1990, 69: 585–592. 10.1111/j.1365-2672.1990.tb01552.xGoogle Scholar
  41. Broxton P, Woodcock P, Heatley F, Gilbert P: Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli . J Appl Microbiol 1984, 57: 115–124. 10.1111/j.1365-2672.1984.tb02363.xGoogle Scholar
  42. Ikeda T, Ledwith A, Bamford C, Hann R: Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta Biomembr 1984, 769: 57–66. 10.1016/0005-2736(84)90009-9View ArticleGoogle Scholar
  43. Allen MJ, Morby AP, White GF: Cooperativity in the binding of the cationic biocide polyhexamethylene biguanide to nucleic acids. Biochem Biophys Res Commun 2004, 318: 397–404. 10.1016/j.bbrc.2004.04.043View ArticleGoogle Scholar
  44. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM: Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol 2011, 45: 283–287. 10.1021/es1034188View ArticleGoogle Scholar
  45. Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A: Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 2006, 22: 9322–9328. 10.1021/la060661vView ArticleGoogle Scholar
  46. Amato E, Diaz-Fernandez YA, Taglietti A, Pallavicini P, Pasotti L, Cucca L, Milanese C, Grisoli P, Dacarro C, Fernandez-Hechavarria JM: Synthesis, characterization and antibacterial activity against gram positive and gram negative bacteria of biomimetically coated silver nanoparticles. Langmuir 2011, 27: 9165–9173. 10.1021/la201200rView ArticleGoogle Scholar
  47. Dutta S, Shome A, Kar T, Das PK: Counterion-induced modulation in the antimicrobial activity and biocompatibility of amphiphilic hydrogelators: influence of in-situ -synthesized Ag − nanoparticle on the bactericidal property. Langmuir 2011, 27: 5000–5008. 10.1021/la104903zView ArticleGoogle Scholar
  48. Saxena A, Tripathi RM, Singh RP: Biological synthesis of silver nanoparticles by using onion ( Allium cepa ) extract and their antibacterial activity. Dig J Nanomater Bios 2010, 5: 427–432.Google Scholar
  49. Nabikhan A, Kandasamy K, Raj A, Alikunhi NM: Synthesis of antimicrobial silver nanoparticles by callus and leaf extracts from saltmarsh plant, Sesuvium portulacastrum L. Colloids Surf B 2010, 79: 488–493. 10.1016/j.colsurfb.2010.05.018View ArticleGoogle Scholar
  50. Jaidev L, Naraismha G: Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity. Colloids Surf B 2010, 81: 430–433. 10.1016/j.colsurfb.2010.07.033View ArticleGoogle Scholar

Copyright

© Ashraf et al.; licensee Springer. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.